The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.

Abstract and Introduction Drugs Used for Ventricular Rate Control Drugs Used to Restore and Maintain Sinus Rhythm Conclusions References Although a large study [58] of over 1500 patients has ...

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.

Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Use of antiarrhythmic drugs or catheter ablation to suppress recurrent ventricular tachycardia is often warranted, but studies comparing the two approaches are limited. New research findings from a ...

CHICAGO, IL—For patients with ischemic cardiomyopathy and ventricular tachycardia (VT) who have an implantable cardioverter-defibrillator (ICD), catheter ablation may be a better first-line therapy ...

Please provide your email address to receive an email when new articles are posted on . In patients with persistent AF, pulsed field ablation was better than drug therapy at preventing arrhythmia ...